Bioengineered CRISPR/Cas9-based transcriptional activators for controlling cell-fate decisions
        
                
        
          
          
        
      
      
      
        
    
            10th November 2020            
          
          Bioengineered CRISPR/Cas9-based transcriptional activators for controlling cell-fate decisions
The following study was conducted by Scientists from University Program in Genetics and Genomics, Duke…
        
				








